Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × elemene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Advanced Primary Liver Cancer 2 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Oxaliplatin 42 Gemcitabine 38 Fluorouracil 36 Capecitabine 28 pembrolizumab 26 Leucovorin 25 Docetaxel 24 Cisplatin 22 Paclitaxel 18 Carboplatin 16 Radiotherapy 15 Bevacizumab 15 Pemetrexed 14 130-nm albumin-bound paclitaxel 14 Irinotecan 13 Nivolumab 11 Albumin-Bound Paclitaxel 11 Ramucirumab 9 Cyclophosphamide 9 zolbetuximab 7 Trastuzumab 7 Radiosurgery 7 Drug Therapy 7 trastuzumab deruxtecan 6 durvalumab 5 Taxes 5 Sorafenib 5 S 1 (combination) 5 Metformin 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Recruiting

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡